MATRIMONY evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-22T14:01:57.891730+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 4599900000.0
- net_income
- 341700000.0
- operating_cash_flow
- 905700000.0
- free_cash_flow
- 797000000.0
- total_assets
- 4404200000.0
- total_liabilities
- 2336700000.0
- total_equity
- 2064699999.0
- cash
- 84300000.0
- total_debt
- 493500000.0
- revenue_growth
- 0.009104071604071562
- earnings_growth
- -0.24536219081272082
- net_margin
- 0.0742842235700776
- roe
- 0.16549619807502117
- debt_to_equity
- 0.23901777509517982
- cash_conversion
- 2.650570676031607
- free_cash_flow_margin
- 0.1732646361877432
- trailing_pe
- 27.73
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-b91ed9e64a8c7cda6cebdeccd78184294e6ec4b80de6c11dd55c7193ef51b4d9
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 948cf0189660a61cbe458deb05f835bcef52a3e08269f56de4364670b93f7935
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: e40d9489037d708f106a8365a5a0183766835b6890d17168523983855e933d4c
- daily-price: 27ccd5cf908bb864f96d67620d09de389ee50c2443effc53af19f6ce8b7fced2
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 497.00.
- The trailing 5-session price return was -7.72%.
- The trailing 20-session price return was -3.37%.
- The trailing 60-session price return was 16.48%.
- The trailing 250-session price return was -3.52%.
- Average cached traded value over twenty sessions was INR 7,229,980.
- The closing price was -11.70% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T14:01:57.891730+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.009104071604071562.
- The cached financial metric net margin is 0.0742842235700776.
- The cached financial metric roe is 0.16549619807502117.
- The cached financial metric debt to equity is 0.23901777509517982.
- The cached financial metric cash conversion is 2.650570676031607.
- The cached financial metric free cash flow margin is 0.1732646361877432.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.